Strategy for the treatment of multiple myeloma utilizing monoclonal antibodies: A new era begins.
about
Spotlight on elotuzumab in the treatment of multiple myeloma: the evidence to dateImmuno-targeting the multifunctional CD38 using nanobodyElotuzumab: The First Monoclonal Antibody for the Treatment of Multiple Myeloma.Nanobodies effectively modulate the enzymatic activity of CD38 and allow specific imaging of CD38+ tumors in mouse models in vivo.Emerging immune targets for the treatment of multiple myeloma.The bone-marrow niche in MDS and MGUS: implications for AML and MM.
P2860
Strategy for the treatment of multiple myeloma utilizing monoclonal antibodies: A new era begins.
description
2015 nî lūn-bûn
@nan
2015年の論文
@ja
2015年論文
@yue
2015年論文
@zh-hant
2015年論文
@zh-hk
2015年論文
@zh-mo
2015年論文
@zh-tw
2015年论文
@wuu
2015年论文
@zh
2015年论文
@zh-cn
name
Strategy for the treatment of ...... antibodies: A new era begins.
@en
type
label
Strategy for the treatment of ...... antibodies: A new era begins.
@en
prefLabel
Strategy for the treatment of ...... antibodies: A new era begins.
@en
P2093
P2860
P1433
P1476
Strategy for the treatment of ...... antibodies: A new era begins.
@en
P2093
Francesca Bonello
Marco Salvini
Sara Bringhen
Valeria Magarotto
P2860
P304
P356
10.3109/10428194.2015.1102245
P577
2015-10-07T00:00:00Z